D. Shemin

发表

Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future Perspectives

L. Dworkin, E. Shaban, G. Bayliss, 2018, Kidney Diseases.

L. Dworkin, D. Shemin, 2008 .

Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure.

J. G. Abuelo, D. Shemin, M. Elnour, 1990, The American journal of medicine.

Residual renal function and mortality risk in hemodialysis patients.

L. Dworkin, D. Shemin, A. Bostom, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.

D. Shemin, A. Brem, C. Lambert, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Thirty-Day Readmission After Medical Versus Endovascular Therapy for Atherosclerotic Renal Artery Stenosis.

D. Kolte, J. Abbott, K. Kennedy, 2020, The American journal of cardiology.

Dialysis in Pregnant Women with Chronic Kidney Disease

D. Shemin, 2003, Seminars in dialysis.

A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients.

Ping-Yu Liu, L. Elzinga, D. Shemin, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of specific causes of renal failure

J. G. Abuelo, D. Shemin, A. Spital, 1995 .

Early dialysis does not significantly increase survival in end-stage renal disease

D. Shemin, 2002 .

Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection

S. Verma, A. Javaheri, M. Kosiborod, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Serum creatinine concentration at the onset of uremia: higher levels in black males.

J. G. Abuelo, D. Shemin, J. Chazan, 1992, Clinical nephrology.

The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities

D. Shemin, C. Lindberg, C. M. Lindberg, 2018, Infection Control & Hospital Epidemiology.

Renal osteodystrophy and dialysis artifacts as indicators of identification.

D. Shemin, N. P. Libbey, J. Chazan, 1994, Forensic science international.

Residual Renal Function in a Large Cohort of Peritoneal Dialysis Patients: Change over Time, Impact on Mortality and Nutrition

A. Kliger, D. Shemin, A. Bostom, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.

I. Rosenberg, K. Lapane, A. Hume, 1996, Kidney international.

Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment.

C. Towe, K. Tashima, J. Rich, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Gram Negative Rod Peritonitis in Peritoneal Dialysis

D. Shemin, 2008, Seminars in dialysis.

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.

J. Selhub, D. Shemin, A. Bostom, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Inpatient Dialysis Planning During the COVID-19 Pandemic: A Single-Center Experience and Review of the Literature

G. Bayliss, D. Shemin, B. Shea, 2020, International journal of nephrology and renovascular disease.

Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.

J. Selhub, D. Shemin, A. Bostom, 1996, Atherosclerosis.

Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients.

I. Rosenberg, P. Jacques, L. Dworkin, 1998, Transplantation proceedings.

Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.

J. Selhub, D. Shemin, A. Bostom, 1995, Atherosclerosis.

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Manesh R. Patel, Neha J. Pagidipati, J. Stehli, 2020, The Lancet.

Sodium balance in renal failure

L. Dworkin, D. Shemin, 1997, Current opinion in nephrology and hypertension.

Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.

E. D’Agata, D. Shemin, D. Tran, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Evaluating Infection Prevention Strategies in Out-Patient Dialysis Units Using Agent-Based Modeling

Joanna R. Wares, Barry Lawson, E. D’Agata, 2016, PloS one.

Lupus Nephritis Mimicking Pyelonephritis in Pregnancy

D. Shemin, B. Anderson, A. Friedman, 2010, Hypertension in pregnancy.

Prevalence and trends of Clostridioides difficile infection among persons requiring maintenance hemodialysis: A systematic review and meta-analysis.

M. Mohamed, D. Shemin, Yousef Elfanagely, 2022, Infection control and hospital epidemiology.

Clostridioides difficile Infection Among Patients Requiring Maintenance Hemodialysis

E. D’Agata, D. Shemin, J. Monteiro, 2021, Kidney medicine.

Treatment of hyperhomocysteinemia in end-stage renal disease.

J. Selhub, D. Shemin, A. Bostom, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.

P. Jacques, L. Dworkin, J. Selhub, 2000, Transplantation.

Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

Z. Massy, P. Jacques, L. Dworkin, 2000, Circulation.

Hypothyroidism-induced Acute Kidney Injury and Hyponatremia.

D. Shemin, Kaelo Moahi, M. Shakoor, 2020, Rhode Island medical journal.

Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures

D. Shemin, Doris Briggs, M. Greenan, 2007, Journal of clinical apheresis.

Clinical outcome in three patients with postpartum hemolytic uremic syndrome treated with frequent plasma exchange.

L. Dworkin, D. Shemin, 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Bloodstream Infections in Hospitalized Hemodialysis Patients

E. D’Agata, D. Shemin, F. Gillani, 2019, Kidney medicine.

Tubular causes of renal failure

D. Shemin, 1995 .

Acute Symptoms Produced by Hemodialysis: A Review of Their Causes and Associations

J. G. Abuelo, D. Shemin, J. Chazan, 1993 .

Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.

L. Medeiros, D. Shemin, A. Esparza, 1995, Archives of pathology & laboratory medicine.

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

P. Wilson, I. Rosenberg, G. Tofler, 1996, Atherosclerosis.

General management of the patient with chronic renal failure

R. Mahnensmith, D. Shemin, 1995 .

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

P. Wilson, P. Wilson, K. Lapane, 1995, Atherosclerosis.

Prevalence of protein malnutrition in children maintained on peritoneal dialysis

D. Shemin, A. Brem, C. Lambert, 2002, Pediatric Nephrology.

Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicators Project

D. Shemin, A. Brem, C. Lambert, 2001, Pediatric Nephrology.

Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.

S. I. Kahn, D. Shemin, J. Chazan, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Abnormalities of lipoprotein metabolism in the nephrotic syndrome.

D. Shemin, A. Bostom, 1991, The New England journal of medicine.

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

I. Rosenberg, R. Rozen, P. Jacques, 1996, Atherosclerosis.

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

I. Rosenberg, P. Jacques, L. Dworkin, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Efficacy and safety of sofosbuvir in the treatment of hep C among patients on hemodialysis: a systematic review and meta-analysis

E. D’Agata, E. Mylonakis, D. Shemin, 2020, Scientific Reports.

Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management.

D. Shemin, 2014, Rhode Island medical journal.

Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.

A. Monaco, L. Dworkin, D. Shemin, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.

L. Bausserman, S. Kahn, K. Lapane, 1999, Journal of the American Society of Nephrology : JASN.

First hemodialysis access selection varies with patient acuity.

A. Friedman, D. Shemin, C. Walworth, 2000, Advances in renal replacement therapy.

Antihypertensive therapy and progression of chronic renal disease

L. Dworkin, D. Shemin, 1999, Current hypertension reports.

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.

R. Janssen, D. Shemin, M. Girndt, 2023, Vaccine.

Use of Amino Acid Peritoneal Dialysate for One Year in a Child on Ccpd

D. Shemin, A. Brem, M. Wolfson, 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients

P. Jacques, L. Dworkin, J. Selhub, 2001 .

Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.

P. Jacques, L. Dworkin, J. Selhub, 2002, Kidney international.

Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.

Z. Massy, P. Jacques, L. Dworkin, 2001, Kidney international. Supplement.

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury.

L. Dworkin, D. Shemin, Douglas Shemin, 2011, Critical care clinics.

Should serum potassium levels be routinely checked after the last dialysis of the week and before the first dialysis of the week?

J. G. Abuelo, D. Shemin, Sumanth Kacharam, 2020, Hemodialysis international. International Symposium on Home Hemodialysis.

Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure.

D. Shemin, P. S. Cohn, S. B. Zipin, 1990, Archives of internal medicine.

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.

R. Wilensky, J. Stehli, K. Kario, 2023, Journal of the American College of Cardiology.